Desensitization of the nicotine‐induced mesolimbic dopamine responses during constant infusion with nicotine
Open Access
- 1 January 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 114 (2) , 454-460
- https://doi.org/10.1111/j.1476-5381.1995.tb13248.x
Abstract
1 The effects of constant nicotine infusions (0.25, 1.0 and 4.0 mg kg−1 day−1) on extracellular dopamine levels in the nucleus accumbens (NAc) and on locomotor activity have been compared with the changes evoked by repeated daily injections (0.4 mg kg−1 day−1 for 5 days) of the drug. 2 The extracellular dopamine concentration in the NAc was significantly increased (P−1, s.c.) in animals which had been pretreated with daily injections of the drug. This effect was accompanied by an enhanced locomotor response to nicotine. 3 The stimulant effects of nicotine on mesolimbic dopamine secretion and on locomotor activity were significantly inhibited (P−1, s.c.) but not by hexamethonium (2.0 mg kg−1, s.c). 4 The constant infusion of nicotine at a rate of 1 and 4 but not 0.25 mg kg−1 day−1 abolished the sensitized dopamine response in the NAc to an injection of nicotine in animals pretreated with the drug. The locomotor responses to nicotine in the nicotine-pretreated rats were significantly attenuated by the infusion of nicotine at all 3 doses, although the nicotine induced locomotor activity, in the rats infused with 0.25 mg kg−1 day−1 was also significantly (PP−1, s.c), were observed 2 and 7 days after termination of the infusion of nicotine (4 mg kg−1 day−1 for 14 days); locomotor responses were enhanced (P<0.01) 1, 2 and 7 days after termination of the infusion. 6 The results suggest that sensitized mesolimbic dopamine responses to nicotine occur as a result of stimulation of centrally located nicotinic receptors but that these receptors may be desensitized during periods of chronic exposure to nicotine at doses which may be relevant to smoking.Keywords
This publication has 28 references indexed in Scilit:
- Systemic nicotine‐induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental areaSynapse, 1994
- Chronic and acute tolerance to subjective effects of nicotinePharmacology Biochemistry and Behavior, 1993
- Aversive environmental stimuli as a factor in the psychostimulant response to nicotinePharmacology Biochemistry and Behavior, 1989
- Effects of chronic nicotine pretreatment on (+)-amphetamine and nicotine-induced synthesis and release of [3H]dopamine from [3H]tyrosine in rat nucleus accumbensJournal of Pharmacy and Pharmacology, 1989
- Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human BrainJournal of Neurochemistry, 1988
- 4‐(O‐Benzylphenoxy)‐N‐Methylbutylamine (Bifemelane) and Other 4‐(O‐Benzylphenoxy)‐N‐Methylalkylamines as New Inhibitors of Type A and B Monoamine OxidaseJournal of Neurochemistry, 1988
- Effect of Chronic Nicotine Administration on Monoamine and Monoamine Metabolite Concentrations in Rat BrainClinical Neuropharmacology, 1987
- Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smokeJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- In Vivo Regulation of [3H]Acetylcholine Recognition Sites in Brain by Nicotinic Cholinergic DrugsJournal of Neurochemistry, 1985
- Effects of dopaminergic nucleus accumbens lesions on the acquisition of schedule induced self injection of nicotine in the ratPharmacology Biochemistry and Behavior, 1982